Skip to main content

Advertisement

Table 3 Association of microalbuminuria with the metabolic syndrome components as dichotomized variables

From: Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population

The metabolic syndrome component Number (Prevalence, %) Unadjusted Adjusted Model 1a Adjusted Model 2b
   Odds ratio (95% CI) P value Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Central obesity 422 (39.1) 3.38 (1.80-6.34) 0.0001 2.52 (1.09-5.83) 0.03 2.24 (0.96-5.24) 0.06
Elevated blood pressure 522 (48.4) 3.16 (1.62-6.18) 0.0007 2.85 (1.22-6.67) 0.02 2.16 (1.01-4.63) 0.04
Elevated fasting plasma glucose 126 (11.7) 3.53 (1.83-6.81) 0.0002 3.03 (1.55-5.94) 0.001 2.57 (1.29-5.11) 0.007
Elevated serum triglycerides 356 (33.0) 2.10 (1.16-3.80) 0.01 1.75 (0.94-3.26) 0.08 1.30 (0.67-2.55) 0.44
Reduced serum HDL cholesterol 87 (8.1) 2.14 (0.93-4.94) 0.07 1.71 (0.71-4.08) 0.23 1.29 (0.51-3.25) 0.59
  1. CI, confidence interval; HDL, high density lipoprotein.
  2. The metabolic syndrome component was defined according to the Adult Treatment Panel III criteria (ATP III) criteria [6]. For further information, see methods.
  3. aAdjusted for sex, age, body mass index, current smoking, current alcoholic intake and use of antihypertensive drugs (except for elevated blood pressure).
  4. bAdditionally adjusted for the other components of metabolic syndrome.